Effect of zoledronic acid (ZA) on bone mineral density (BMD) in premenopausal women who develop ovarian failure (OF) due to adjuvant chemotherapy (AdC): First results from CALGB trial 79809
- Citation:
- J Clin Oncol vol 26 (suppl) abstr 512
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 118
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- C. L. Shapiro S. Halabi G. Gibson R. J. Friedlander J. Kirshner W. Sikov E. P. Winer C. A. Hudis C. Issac
- Networks:
- Study
- CALGB-79809
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: